易生活控股(00223.HK)接獲法律程序通知書
格隆匯4月22日丨易生活控股(00223.HK)公告,於2025年4月15日,公司接獲一名申索人針對公司(作爲答辯人)提交的法律程序通知書,指稱公司違反公司與申索人就一項涉及公司的集資交易所訂立的協議項下的多項聲明及保證。申索人要求(其中包括)公司賠償因公司據稱違反協議項下的聲明及保證而蒙受的損失、覆核及調查有關事宜所產生的費用及開支、法律程序的法律費用及開支及其任何利息,以及適當的任何其他補救。法律程序通知書中並未訂明申索金額。
交易乃於董事會重組於2025年3月11日股東特別大會結束後生效之前訂立。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.